{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"BioBreakthroughs","title":"#48 - Michael Oleksiw, CEO at Pleio","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/3f3cac1f\"></iframe>","width":"100%","height":180,"duration":867,"description":"Join us on the latest episode! Our Guest: Michael Oleksiw, CEO at Pleio.What you'll get out of this episode:Human + AI Synergy: Pleio combines emotionally aware AI with peer-to-patient support to boost medication adherence.Overcoming Emotional Barriers: Emotions like fear, loneliness, and stigma are major challenges after diagnosis.Real-World Impact: Pleio's approach improved adherence rates by up to 28% in GLP-1 medication trials.Ethical AI in Healthcare: Patient data is de-identified and overseen by a medical board to ensure ethical use.Laser Focus on Loneliness: Pleio’s next frontier is tackling loneliness as a primary emotional barrier in healthcare.To Learn More About Our Guest And Their Company:Guest LinkedIn https://www.linkedin.com/in/michaeloleksiw/Company LinkedIn https://www.linkedin.com/company/pleio-inc/Website http://www.pleio.comOur sponsor for this episode are:Sage Growth Partners https://sage-growth.com/BioBreakthroughs is part of the Slice of Healthcare podcast network:LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/","thumbnail_url":"https://img.transistorcdn.com/roxGfgcNItysBs3fg55SsdSx4l_Pbz86Ktm2KMDYkR4/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9zaG93/LzQwNjg1LzE2ODE5/MzQxODQtYXJ0d29y/ay5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}